The shortcomings of traditional pulse oximetry, a technique routinely employed in hospitals, ambulances, and home care, have become increasingly apparent. These devices monitor blood oxygen saturation, a parameter that generally remains stable until critical oxygen deprivation occurs, often signaling life-threatening conditions. According to Brian Pogue, Robert A. Pritzker Professor of Biomedical Engineering at Dartmouth and co-author of the study, “Relying solely on blood oxygen levels is insufficient. It’s the tissue oxygenation—the subtle fluctuations within cells—that truly reflects organ function and overall health dynamics.” This insight underpins their quest to devise a method attuned to intracellular oxygen levels rather than macroscopic blood oxygenation.

Historically, accurate tissue oxygen measurement has necessitated expensive and cumbersome imaging instruments or invasive procedures involving foreign sensors implanted in or attached to the body. These constraints have limited the accessibility and practicality of continuous tissue oxygen monitoring, relegating it to specialized clinical settings. The Dartmouth team’s innovative solution circumvents these barriers by combining a standard smartphone camera with a pulsed LED illumination system and a topical cream that activates endogenous oxygen-sensitive molecules within the tissue. The elegance of this approach lies in its affordability, portability, and non-invasive nature, enabling frequent and user-friendly monitoring outside clinical environments.

At the heart of this technology is Protoporphyrin IX (PpIX), a naturally synthesized molecule ubiquitous in living cells and integral to heme biosynthesis. PpIX exhibits a distinct photophysical behavior where its fluorescence—specifically delayed fluorescence—is quenched in the presence of oxygen. By applying a cream that stimulates PpIX production in target tissues and employing a pulsed LED to excite the molecule, the smartphone camera captures the emitted delayed fluorescence signals. The intensity of this signal inversely correlates with tissue oxygen levels, thus serving as a precise and direct indicator of intracellular oxygenation.

The team has ingeniously adapted the time-sequenced imaging capabilities inherent in smartphone cameras to capture the subtle delayed fluorescence of PpIX. Although the principle of using mobile devices for physiological measurements is not unprecedented, harnessing endogenous oxygen reporters in this way is a transformative leap. Co-author Jason Gunn and lead researcher Protik Chandra Biswas have optimized the synchronization of LED pulses and camera exposure to isolate the faint PpIX signals from background noise, enabling reliable quantification of tissue oxygen dynamics in vivo.

This method holds particular promise for diagnosing and managing peripheral vascular diseases, where tissue oxygenation metrics critically inform clinical decisions such as the timing of vascular surgeries or the necessity for limb amputation. The morbidity and healthcare costs associated with these procedures are significant, underscoring the need for more sensitive and accessible monitoring tools. By offering a convenient mechanism for day-to-day evaluation of tissue oxygen levels, the smartphone-based system empowers patients and clinicians alike to make more informed decisions, potentially reducing unnecessary interventions and improving outcomes.

Beyond vascular health, the technology demonstrates remarkable utility in monitoring tissue repair and infection. Inflamed or healing tissue exhibits characteristic oxygenation patterns that can be tracked without the requirement for the activating topical cream, as inflammation naturally elevates PpIX production. This allows clinicians to monitor the trajectory of healing or detect early signs of infection through simple, frequent assessments, shifting the paradigm towards proactive and personalized care.

The research team is not resting on this initial success; they are extending investigations to encompass burn wound analysis in collaboration with a burn surgeon in Wisconsin. By longitudinally monitoring PpIX fluorescence and oxygenation in wounded tissue, they aim to clarify diagnostic criteria for interventions such as skin grafting. This capability could revolutionize burn care by enabling real-time, bedside decision-making that enhances recovery and reduces complications.

A pivotal advantage of this technology is its scalability and cost-effectiveness. High-end camera systems typically employed for tissue oxygen imaging are prohibitively expensive and stationary, unsuitable for routine use. The Dartmouth approach harnesses ubiquitous smartphone hardware, democratizing access to sophisticated biomedical monitoring. Daily tracking over extended periods becomes feasible, offering unprecedented insights into dynamic physiological changes that are otherwise difficult to capture.

To complement the hardware innovation, the Dartmouth team has enlisted undergraduate students through their First-Year Research in Engineering Experience program to develop an intuitive and user-friendly mobile application. This app aims to facilitate seamless daily monitoring, data visualization, and potentially integration with healthcare providers for remote patient management, representing a critical step toward widespread adoption.

The convergence of biomedical engineering, photophysics, and mobile technology embodied in this research signals a new era in personalized medicine. By translating complex intracellular oxygen measurements into accessible formats, this platform could significantly enhance early diagnosis, chronic disease management, and therapeutic outcomes across a spectrum of health conditions. As the technology matures, it is poised to empower patients with actionable information at their fingertips, embodying the future of home-based healthcare innovation.

This study, published in the esteemed journal Biosensors and Bioelectronics, epitomizes the potential of interdisciplinary collaboration to push the boundaries of diagnostic tools. The work stands as a testament to how leveraging endogenous biological markers, combined with everyday technologies, can yield powerful solutions to longstanding medical challenges. The researchers anticipate rapid progress as ongoing validations and clinical trials further define the scope and efficacy of their tool.

In conclusion, Dartmouth’s smartphone-based tissue oxygen monitoring system exemplifies the transformative potential of integrating biological insights with consumer technology. It represents a quantum leap from invasive or static measurements to a dynamic, user-centric approach. As validation and application expand, this innovation could become a cornerstone in vascular disease management, wound healing evaluation, infection tracking, and beyond — dramatically improving patient care through technology that is as simple as it is revolutionary.

Subject of Research: Animal tissue samples

Article Title: Intracellular oxygen measurement in vivo by smartphone readout of endogenous Protoporphyrin IX delayed fluorescence

News Publication Date: 1-Feb-2026

Web References:
https://www.sciencedirect.com/science/article/pii/S0956566326001041?via%3Dihub
http://dx.doi.org/10.1016/j.bios.2026.118472

Keywords

Medical technology, Biomedical engineering, Tissue oxygen monitoring, Protoporphyrin IX, Smartphone diagnostics, Peripheral vascular disease, Wound healing, Infection monitoring, Personalized medicine, Non-invasive sensors, Fluorescence quenching, Clinical diagnostics

Carbon nanotubes, particularly single-wall configurations, possess unique electrical and chemical properties that can be fine-tuned depending on their chirality—the specific way in which the graphene sheet is rolled into the tubular structure. Traditionally, the production process of these nanotubes generated a mixture of conductive and semi-conductive variants, posing a challenge for researchers aiming for specificity in application. The recent innovations from the University of Turku address this challenge head-on by introducing techniques for separating nanotubes based on their chirality. By doing so, researchers can exploit the distinct electrochemical properties that arise from even subtle differences in chirality to develop a new class of sensor materials.

This innovative technique, spearheaded by Han Li, a Collegium Researcher in materials engineering, has paved the way for a detailed understanding of how these tiny structures act in sensor technologies. Researchers successfully distinguished between carbon nanotubes that exhibit very similar chiral characteristics, shedding light on their electrochemical responses. This differentiation is crucial, as the nuances of chirality can significantly influence the efficacy of sensors. “Although the difference in the chirality of the nanotubes is very slight, their properties are very different,” notes Ju-Yeon Seo, a Doctoral Researcher involved in the study. Such insights could propel the next wave of sensor technology development, particularly in areas that demand high precision.

Central to the effectiveness of these sensors is the ability to accurately control the concentration of the nanotubes used. The study achieved this feat by fabricating sensors that consist solely of carbon nanotubes, contrasting with traditional methods where additional surfactants are often incorporated. This purity not only enhances the performance of the sensors but also allows for a more accurate comparison of each nanotube’s properties. One of the striking findings from the research is that a specific type of nanotube—designated (6.5)—was observed to possess a greater efficiency in adsorbing dopamine than another variant labeled (6.6). This differential performance underscores the importance of chirality in nanomaterial applications.

Adsorption plays a pivotal role in sensor design, especially in the context of detecting low concentrations of biomolecules. The ability of materials to bind with other atoms or molecules is critical when it comes to measuring substances present in minute quantities. In the world of biomedical sensors, where hormones like estrogen exist in levels that can be millions of times lower than glucose, the performance of sensor materials can dictate the success of clinical diagnoses and ongoing health assessments. Researchers at the University of Turku are dedicated to developing biosensors that not only meet but exceed the current standards for accuracy and sensitivity.

The innovative research findings also suggest that controlling the electrochemical properties of carbon nanotubes could lead to refinements in how we understand hormone fluctuations within the human body. As the team looks forward, computational models may be employed to optimize chirality further, tailoring the nanotube materials toward specific hormones or other biomolecules of interest. This tailored approach could transform our ability to conduct dynamic health assessments, allowing for a deeper understanding of hormonal health and overall bodily functions.

The implications of this research are broad, reaching into the realm of continuous health monitoring—a concept that could revolutionize personal healthcare. Imagine wearing a device equipped with sensors utilizing carbon nanotubes that can continuously monitor hormone levels, offering real-time data to patients and healthcare providers alike. Such advancements could pave the way for personalized treatment strategies and immediate interventions as fluctuations in critical biomolecules are detected.

As the research continues, the focus remains on not only improving the sensitivity and specificity of these sensor systems but also ensuring they maintain functionality within biological environments. The materials used must withstand the complexities of biological interactions while delivering reliable measurements over time. The Materials in Health Technology group at the University of Turku aims to tackle these challenges head-on, ensuring that the next generation of biosensors are not only effective but also practical for everyday use.

In summary, the innovative breakthroughs achieved by the University of Turku highlight the role nanotechnology plays in modern healthcare. By leveraging the unique properties of carbon nanotubes and refining their applications through advanced research methods, the potential for creating highly sensitive, accurate biosensors is within reach. These advancements signify a shift toward more proficient diagnostic methods that could vastly improve the understanding of hormonal health and other critical biological metrics. The future of healthcare may well depend on these small yet powerful materials, reshaping how we monitor and respond to health issues in real-time.

By embarking on this research journey, the University of Turku is not just contributing to scientific knowledge; they are laying the groundwork for a new paradigm in healthcare technology. With carbon nanotubes at the forefront, the promise of increased accuracy and sensitivity in biosensors may soon translate into tangible benefits for patients, paving the way for a healthier future.

Subject of Research: Nanotechnology and carbon nanotubes in healthcare sensor development
Article Title: Single-chirality single-wall carbon nanotubes for electrochemical biosensing
News Publication Date: 11-Feb-2025
Web References: DOI link
References: Physical Chemistry Chemical Physics
Image Credits: Mikael Nyberg

Keywords

Nanotubes, sensors, carbon nanotubes, healthcare, biosensing, chirality, hormonal monitoring, electrochemistry, University of Turku, nanotechnology.